MARIA WOODSIDE: Open Payments
NPI 1669978458 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 26 payments from 9 companies in 2025. Trend: 2023 $593 · 2024 $932 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| Teleflex LLC | 5 | $280 |
| Medtronic, Inc. | 2 | $166 |
| ABBVIE INC. | 6 | $137 |
| Sumitomo Pharma America, Inc. | 4 | $99 |
| 180 Medical, Inc. | 3 | $63 |
| Endo USA, Inc. | 2 | $45 |
| TOLMAR, INC. | 2 | $34 |
| Myriad Genetic Laboratories, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $18 |
Products named: UROLIFT, INTERSTIM, BOTOX, GEMTESA, BARRIGEL, XIAFLEX, PROLARIS, AVEED.
Industry payments across TX — which companies pay providers there.
